CClinicalTrials.gg
TerminatedNCT00935207Updated May 3, 2013

Study of the Impact of a Pain Diary in Pediatric Patients

An observational study in Pain, sponsored by University of Mississippi Medical Center. Terminated at 1 site in United States. Open to participants aged 3 Years to 19 Years. Per ClinicalTrials.gov, last updated 2013-05-03.

Sponsored by University of Mississippi Medical Center · Observational

Why this study was terminated
Poor enrollment and data collection
Study type
Observational
Time perspective
Prospective
Enrollment
8
Ages
3 Years to 19 Years
Sex
All
01

Study summary

The purpose of this study is to show the impact of a pain diary on the communication of pain by pediatric patients. Participants will be given a pain diary after consent and asked to complete the record each time they have pain. A survey about the efficacy of the pain diary will be taken prior to discharge by the nurse, physician, patient and parents. The hypothesis is that the pain diary will improve the communication.

02

Conditions studied

  • Pain

Keywords

  • Pain
  • Pediatric Pain
  • Pain Diary
  • Pediatric Pain Measurement
  • Pain Measurement
03

In context

Lead sponsor

University of Mississippi Medical Center is the lead sponsor of 125 studies on the registry; 19 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 4 (57%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Inpatients at the Blair E. Batson Hospital for Children 3-19 years of age, receiving regular controlled substance analgesic defined as: codeine with acetaminophen, fentanyl, hydromorphone, meperidine, morphine, oxycodone with acetaminophen, propoxyphene with acetaminophen, and hydrocodone with acetaminophen.

Inclusion criteria

  • Inpatients at the Blair E. Batson Hospital for Children 3-19 years of age, receiving regular controlled substance analgesic defined as: codeine with acetaminophen, fentanyl, hydromorphone, meperidine, morphine, oxycodone with acetaminophen, propoxyphene with acetaminophen, and hydrocodone with acetaminophen.

Exclusion criteria

Exclusion Criteria:

  • Admitted to the Pediatric Intensive Care Unit
  • Surgical patients, defined as patients having surgery since admission other than minor procedures
  • Patients anticipated to receive pain medication for less than 24 hours
  • Patients unable to verbally communicate their pain
05

Study design

Time perspective
Prospective
Enrollment
8 participants (actual)
Patient registry
No

Groups and cohorts

  • Pediatric Pain Diary

    Patients will be give a pain diary to complete.

    Other: Pediatric Pain Diary

Interventions

  • OtherPediatric Pain Diary

    Pain diary designed for pediatric patients

06

What researchers measure

Primary outcomes

  1. Child Survey

    Time frame: Hospital discharge

  2. Parent Survey

    Time frame: Hospital Discharge

  3. Nurse Survey

    Time frame: Hospital Discharge

  4. Physician Survey

    Time frame: Hospital Discharge

07

Study locations

1 site
  • University of Mississippi Medical Center
    Jackson, Mississippi 39216, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 3, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00935207
Lead sponsor
University of Mississippi Medical Center
Responsible party
Andrew Ostrenga (Pharmacist, University of Mississippi Medical Center) — Principal investigator
First posted
Jul 8, 2009
Start date
Jun 2009
Primary completion
Dec 2011
Completion
Dec 2011
Last update
May 3, 2013

Study contacts

Andrew Ostrenga, Pharm.D.
principal investigator · University of Mississippi Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in May 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion